+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

From
From
From
From
From
HER2-Positive Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

HER2-Positive Gastric Cancer - Global Strategic Business Report

  • Report
  • November 2026
  • 281 Pages
  • Global
From
Soft Tissue Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Soft Tissue Sarcoma - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Radioligand Therapy - Global Strategic Business Report - Product Thumbnail Image

Radioligand Therapy - Global Strategic Business Report

  • Report
  • November 2026
  • 381 Pages
  • Global
From
Oncology Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Oncology Clinical Trials - Global Strategic Business Report

  • Report
  • November 2026
  • 283 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report 2026 - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 246 Pages
  • Global
From
Oncology Based in-Vivo CRO - Global Strategic Business Report 2026 - Product Thumbnail Image

Oncology Based in-Vivo CRO - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 129 Pages
  • Global
From
From
From
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more